content

Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation

Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead program to identify SHP2 degraders.  SHP2 is a tyrosine-specific phosphatase implicated in human...

Global Pharmaceutical Contract Packaging Is On The Rise

Grand View Research's pharmaceutical packaging industry data compilation encompasses market size projections, trade data, pricing intelligence, competitive benchmarks, macro-environmental analysis, and studies on regulatory...

Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment

A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for...

Career Advancement Opportunities for Clinical Pharmacists

Clinical pharmacists play a vital role in the healthcare system, ensuring the safe and effective use of medications for patients. Their responsibilities go beyond...

Cell And Gene Therapy Market Soars, Forecasted At $82.24B

The global cell and gene therapy market has witnessed remarkable growth, with a market size of USD 15.46 billion in 2022. Projections indicate that...

Growing Demand Reshaping The Future of Aseptic Fill Finish

It's important to highlight that aseptic fill finish operations demand skilled personnel, specialized automated equipment, a controlled cleanroom environment, and constant supervision to maintain...

Automation Technology Reshaping The Prefilled Syringe Sector

Over the last two decades, technology has greatly expanded our capabilities and, consequently, raised expectations for manufacturers. These evolving capabilities have often aligned with,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read